Skip to content
PeptideAgent

Clinics in Arizona

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Arizona law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Arizona at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Arizona

No verified clinics serving Arizona are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Arizona

Yes. An Arizona resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from an Arizona-licensed provider or from an out-of-state provider registered under A.R.S. 36-3606, including by telehealth under A.R.S. 36-3601 through 36-3607 (HB 2454, 2021), and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by an Arizona-permitted pharmacy or a nonresident pharmacy holding an Arizona nonresident permit. Arizona is one of the more open telehealth states: the statute covers asynchronous care and lets qualifying out-of-state providers register instead of obtaining a full Arizona license. [1] [2] [3] [4] [5] [6]

Compounded GLP-1 access in Arizona

Arizona patients using telehealth GLP-1 programs should confirm that the prescriber is Arizona-licensed or registered under A.R.S. 36-3606 and that the dispensing pharmacy holds an Arizona nonresident permit. [3] [5] [7]

Research use only sellers in Arizona

A.R.S. 32-1931 and rule R4-23-607 prohibit a nonresident from selling or distributing prescription-only drugs into Arizona without a Board nonresident permit, and "research use only" peptides marketed for injection are unapproved new drugs under 21 U.S.C. 331 regardless of labeling. [3] [8]

How to check a clinic in Arizona

  1. Confirm the prescribing clinician's license with the Arizona medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Arizona State Board of Pharmacy license lookup. [1] [2] [3] [6]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Arizona. [3] [8]

Common questions in Arizona

Can I get a GLP-1 prescription in Arizona through telehealth without seeing a doctor in person?

Yes. A.R.S. 36-3602 holds telehealth to the same standard of care as in-person care and the definition of telehealth includes asynchronous store-and-forward, so an Arizona-licensed or Arizona-registered provider may evaluate you remotely and prescribe semaglutide or tirzepatide, which are not controlled substances. [4] [5]

All peptide legal questions for Arizona

Sources

  1. [1]Arizona State Board of Pharmacy
  2. [2]Arizona Administrative Code R4-23-410, Current good compounding practices
  3. [3]Arizona Administrative Code R4-23-607, Nonresident permits (implementing A.R.S. 32-1931)
  4. [4]Arizona Revised Statutes 36-3602, Telehealth; standard of care; requirements
  5. [5]Arizona Revised Statutes 36-3606, Interstate telehealth services; registration; requirements
  6. [6]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  7. [7]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  8. [8]21 U.S.C. 331, Prohibited acts